Most likely, age, coupled to a higher number of female patients contributing tumors to the G3/NF1 subgroup, explains the balanced distribution of the major subgroups in the Validation cohort, and suggests age and sex dependence for glioblastoma molecular profiles. Here, NF1 is linked to glioblastoma.